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T he Fall 2019 edition of Neurotransmitter focuses on the national epidemic of acutetraumatic brain injury (TBI) through the multi-faceted lens of the George Washington University (GW).GW Hospital’s Level 1 Trauma Center cares for these patients in the minutes andhours after injury, often quite literally bringing them back to life. The journey to recov-ery takes a team of therapists, emergency room physicians, neurosurgeons, nurses,psychiatrists, and rehabilitation specialists to restore their lives, which often are trans-
formed by their experiences. 
The most severe TBI cases are categorized as disorders of consciousness, leaving
patients with devastating symptoms. Unfortunately, clinical research for these seri-
ously ill patients is limited, in large part due to a lack of assessment tools to measure
recovery of consciousness. To address this gap, Trudy Mallinson, PhD, from the GW
School of Medicine and Health Sciences (SMHS) Department of Clinical Research
and Leadership, has been developing a “Disorders of Consciousness Scale” to en-
able clinical researchers to measure their work with severe TBI patients. Chronic brain
injury is also the focus of Robert W. Turner II, PhD, also in the Department of Clinical
Research and Leadership at SMHS. He’s exploring the individual social impacts of TBI
on a special population: professional football players who suffer TBI as an inherent
consequence of the sport. 
GW recently received several prestigious awards that refect the commitment our
clinical partnership has toward treating brain injury. GW Hospital was honored by the
American Heart Association/American Stroke Association with its highest award for
advancing the comprehensive care of stroke patients. Henry J. Kaminski, MD, earned
one of only 25 rare disease network grants from the National Institutes of Health (NIH)
to provide an infrastructure to study the rare autoimmune disease myasthenia gravis.
Sally Moody, PhD, the chair of the Department of Anatomy and Cell Biology at SMHS,
received an NIH grant to evaluate the genetic basis of developmental disorders.
The SMHS community recently welcomed Sanjay B. Maggirwar, PhD, as the new
chair of the Department of Microbiology, Immunology, and Tropical Medicine. His
research addresses how HIV may produce accelerated vascular aging, which would
predispose individuals to stroke at an early age. 
We believe these and other stories make it evident that GW is at the forefront of the
care of traumatic brain injury, as well as many other areas of brain health. We hope you
agree and that you enjoy this edition of Neurotransmitter. Please feel free to contact
us with any questions. 
ANTHONY CAPUTY, MD HENRY J. KAMINSKI, MD 
Chair, Department of Neurosurgery, Chair, Department of Neurology,
and Rizzoli Professor and Meta Amalia Neumann
 of Neurological Surgery Professor of Neurology 
JAMES L. GRIFFITH, MD ROBERT MILLER, PhD 
Chair, Department of Vice President for Research
Psychiatry and Behavioral Sciences, Senior Associate Dean for Research,
and Leon Yochelson Professor of Vivian Gill Distinguished Research Professor,
Psychiatry and Behavioral Sciences and Professor of Anatomy and
Regenerative Biology 
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RAPID STROKE CARE 
Timing is everything when it comes to stroke care, and thanks to advanced 
brain imaging software, the George Washington University (GW) Hospital 
can now make faster care decisions for patients experiencing a stroke. 
The hospital’s new RAPID CT Perfusion software streamlines treat-
ment decisions for doctors when patients present to the hospital with 
a stroke more than six hours after the event occurred. 
In the past, patients who arrived in the later stages of a stroke 
would not have been candidates for aggressive stroke treatment 
because it was diffcult for doctors to determine the amount of brain 
damage, and whether more damage was imminent, said Kathleen 
Burger, DO, director of the GW Hospital Comprehensive Stroke 
Center. 
Now, in only 90 seconds, the RAPID software can generate infor-
mation on how much damage has occurred in the brain and what areas 
have not yet been affected but are still at risk as time goes on. Burger said 
that data gives doctors information to help them determine the effcacy of 
certain surgical procedures. 
TOP HONOR 
GW Hospital received the highest honor awarded for stroke treatment by
the American Heart Association/American Stroke Association. The award
recognizes GW Hospital’s commitment to stroke treatment. 
ON THE HONOR ROLL 
The George Washington University 
(GW) Hospital received the American 
Heart Association/American Stroke
Association’s (AHA/ASA) Get With 
The Guidelines® Target: Stroke Honor 
Roll Elite Plus Gold Plus Quality 
Achievement Award. The award is the 
highest stroke recognition possible 
from the organizations. It recognizes 
GW Hospital’s commitment to 
providing the most appropriate 
stroke treatment according to
nationally recognized, research-based 
guidelines. 
To qualify for the Target: Stroke 
Elite Plus Honor Roll, GW Hospital had 
to meet quality measures developed 
to reduce the time between the 
patient’s arrival at the hospital and 
treatment with the clot-buster tissue
plasminogen activator. 
According to the AHA/ASA, stroke 
is the ffth-leading cause of death and 
a leading cause of adult disability 
in the United States. The award 
program is the association’s hospital-
based quality improvement effort 
that provides hospitals with tools and 
resources to increase adherence to 
the latest guidelines. 
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UNDERSTANDING THE DEVELOPMENT
OF STATE DEPENDENCE AND CONTINUITY 
A team from the George Washington University School of Medicine and Health Sci-
ences (SMHS) has published a study in the Journal of Neuroscience suggesting the 
thalamus, a tiny nucleus deep in the brain, controls the development of state depen-
dence and continuity. 
Previously, it was thought that to be fully functioning, the brain needed to achieve 
two milestones: continuity, meaning the brain is always active; and state dependence, 
meaning brain activity is modulated by sleep, waking, and attention. The circuit mecha-
nisms behind the development of continuity and state dependence have been widely 
assumed to be located in the cerebral cortex. 
“Our results indicate that cellular changes in the thalamus relay function may be criti-
cal drivers for the maturation of background activity,” said Matthew Colonnese, PhD, 
associate professor of pharmacology and physiology at SMHS. “Humans undergo de-
velopmental transitions in brain activity before and near birth.” 
Drawing on previous work by Colonnese, his team used advanced techniques to re-
cord simultaneously from multiple brain regions to pinpoint the circuit change respon-
sible for the acquisition of continuity and state dependence measured in the sensory 
cortex. They were surprised to learn that activity changes in the thalamus, which could 
explain most of these critical developmental milestones. 
GW HOSPITAL EXPANDS ACCESS THROUGH HELIPAD 
In Spring 2019, District of Columbia Mayor Muriel 
Bowser signed a bill to allow the George Washing-
ton University (GW) Hospital to construct a heli-
pad at its Foggy Bottom facility. 
The approval followed unanimous support 
from the D.C. City Council and its Committee of 
the Whole. The helipad, which opened in Novem-
ber 2019, expands access to GW Hospital’s lifesav-
ing critical care services, including its Level I Trau-
ma Center care and comprehensive stroke care. 
“We would like to thank everyone who assisted 
us through this important pursuit, including our
patients, their loved ones, our community part-
ners, and city and federal government representatives, as well as all of our employees 
and providers,” said Kimberly Russo, MBA, MS, CEO of the GW Hospital. 
STUDYING GENES 
LINKED TO BOS 
Craniofacial abnormalities
are among the most preva-
lent birth defects, which 
include branchiootorenal
spectrum disorders (BOS).
Researchers at the George 
Washington University (GW) 
received a $1.9 million grant 
from the National Institutes 
of Health to study the known 
and unknown genes associ-
ated with BOS. 
The research will focus 
on mutations in two genes 
linked to BOS, SIX1 and EYA1, 
according to Sally A. Moody, 
PhD, chair of the Department 
of Anatomy and Cell Biology 
at the GW School of Medi-
cine and Health Sciences 
(SMHS), a principal investiga-
tor on the grant. 
“We hypothesize that
there are other key co-factor
proteins that bind to SIX1 to
regulate its activity, and that
mutations in these co-factors
contribute to the unknown
causes,” Moody said. “We
hope to identify these ad-
ditional genes, which could
lead to more comprehensive
screening for infants with sus-
pected hearing impairment.” 
Other principal investiga-
tors include Karen Neilson,
PhD, assistant research 
professor of anatomy and 
cell biology at SMHS; Domi-
nique Alfandari, PhD, of the 
University of Massachusetts
Amherst; and Francesca Pi-
gnoni, PhD, of SUNY Upstate 
Medical University. 


















HIV-1 DEMENTIA RESEARCHER  
SANJAY MAGGIRWAR JOINS SMHS 
Sanjay B. Maggirwar, PhD, 
MBA, who has vast experi-
ence researching underly-
ing causes of HIV-associated 
conditions, recently began
his tenure at the George 
Washington University (GW) 
School of Medicine and 
Health Sciences as chair of 
the Department of Micro-
biology, Immunology, and
Tropical Medicine. 
His main research focus is 
on the infammatory second-
ary complications of HIV in-
fection experienced by those living longer with the disease, compared to their aging, 
uninfected counterparts. Maggirwar is exploring the infammatory mechanisms associ-
ated with HIV-1 dementia. He also leads research projects looking at platelet-mediated 
neuroinfammatory responses to HIV, accelerated vascular aging in those undergoing 
combination antiretroviral therapy, and more. 
Maggirwar has published nearly 100 research articles in peer-reviewed journals and 
has been invited to give seminars and present at conferences and symposia around the 
world. In 2017, he received the “School of Medicine and Dentistry Faculty Academic 
Mentoring Award” from the University of Rochester Medical Center and, in 2016 he 
received the “T32 Outstanding Program Director” award. He was also a recipient of the 
“Distinguished Service Award” from the Society on Neuroimmune Pharmacology.
In addition to providing management and leadership to the department, Maggirwar
is responsible for maintaining an active, externally funded research program; oversee-
ing the department’s research centers and collaborative research partnership; partici-
pating in and coordinating the educational programs in the department; and engaging 
in service to the school and university. 
SANJAY B. MAGGIRWAR, 
PhD, MBA, (center) has vast ex-
perience researching underlying
causes of HIV-associated condi-
tions. He recently began his ten-
ure at the GW School of Medicine
and Health Sciences as chair of the
Department of Microbiology, Im-
munology, and Tropical Medicine.
Sanjay Maggirwar has 
published nearly 100 
research articles in 
peer-reviewed journals 
and has been invited 
to give seminars and 
present at conferences 
and symposia 
around the world.
LINKING NERVOUS SYSTEM STRESS TO FATTY LIVER DISEASE 
Non-alcoholic fatty liver disease (NAFLD), the accumulation of fat in the liver of peo-
ple who drink little or no alcohol, is believed to be generated and maintained 
by endoplasmic reticulum (ER) stress, a protein folding process in the brain. 
Researchers at the George Washington University (GW) received more than 
$2.4 million from the National Institutes of Health to investigate ER stress. 
NAFLD is a signifcant risk factor for Type 2 diabetes, insulin resistance, 
and hepatic carcinoma, and incidence of the disease is increasing with the 
obesity epidemic in the United States. The researchers, led by Colin Young, 
PhD, assistant professor of pharmacology and physiology at the GW School of 
Medicine and Health Sciences, aim to better understand the role of forebrain and 
hypothalamic ER stress in obesity induced hepatic sympathetic overactivity and 
NAFLD development.
Young and his team will examine the role of ER stress in the activation of activator 
protein-1 (AP-1) — a transcription factor that regulates gene expression in response 
to a variety of stimuli — in hypothalamic neurons during the development of NAFLD. 
THE LINK BETWEEN
ER AND NAFLD 
Researchers at GW received
a grant from the National
Institutes of Health to
investigate endoplasmic
reticulum stress, which
is believed to cause non-
alcoholic fatty liver disease. 
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BY THOMAS KOHOUT 
E 
ach year, close to 3 million Traumatic 
Brain Injury (TBI)-related emergencies
arrive at hospitals and ambulatory care 
centers across the country, accord-
ing to the Centers for Disease Control. 
While many of those are relatively mi-
nor, stemming from a fall or a bump on the head, 
more serious cases can result in a disruption of nor-
mal brain function, bringing on an extended period
of unconsciousness. 
The more severe instances are categorized as 
Disorders of Consciousness, with symptoms rang-
ing from a lack of concentration to chronic coma to 
brain death. Considering the number of people ex-
periencing some type of serious brain injury annu-
ally, you might think there would be a wealth of clini-
cal trials to address rehabilitation for these patients. 
Unfortunately, there aren’t.
“There really hasn’t been a successful clinical trial 
for severe TBI patients. They generally get stopped 
early, or they don’t appear to be effective,” explains 
Trudy Mallinson, PhD, OTR/L, FAOTA, FACRM, as-
sociate dean for research in health sciences and 
associate professor of clinical research and leader-
ship and of health, human function, and rehabilita-
tion sciences at the George Washington University 
School of Medicine and Health Sciences. 
A key criticism of these trials, Mallinson explains, 
is there aren’t good assessment tools to measure re-
covery of consciousness. 
To address that gap, Mallinson and Theresa 
Bender Pape, DrPH, clinical neuroscientist with the 
Edward Hines Jr. Veterans Administration (VA) Re-
search and Development Service and a research 
associate professor at Northwestern University’s
Feinberg School of Medicine, have collaborated on 
a series of studies, largely funded by the VA Health 
Services Research and Development Service and 
the Department of Defense, to establish and devel-
op the Disorders of Consciousness Scale, or DOCS-
25: a tool enabling clinical researchers to measure 
their work with severe TBI patients. 
The tool uses a rating system consisting of 25 
stimuli contained in four sensory domains to evalu-
ate patients based on their responses. The four neu-
robehavioral domains assess specifc capabilities: 
Auditory/Language, response to a voice or a com-
mand; Somatosensory, dealing with touch such as
light touch or heavy pressure, hot or cold; Visual, a 
patient’s ability to focus on and track an object or 
face; and Gustation/Olfactory, relating to taste or 
smell, such as sweet or sour. 
Responses are scored based on the patient’s best 
overall observable response to a sensory stimuli. Us-
ing a psychometric approach called Rasch analysis, 
these researchers have ordered the sensory items 
from low to high in terms of their relative diffculty 
to respond to. 
“Our data show the items form a really nice hierar-
chy,” Mallinson says. “We are pretty convinced about
the validity of DOCS-25. We know it’s reliable.” 
The next big hurdle is establishing a minimally 
clinically important difference (MCID); basically fnd-
ing out how much change in the measurement mat-
ters to patients, researchers, and clinicians. While 
developing DOCS-25, Mallinson and Pape realized 
none of the assessment tools, including DOCS, had 
a well-established MCID. 
“If you have a 2-point change, does that matter?” 
asks Mallinson. “How much change is enough that 
researchers can say, ‘yes, that’s a real change?’ The 
reason that’s important is because that’s what you 
power clinical trials on. If you believe your clinical 
trial is going to produce a 6-point clinical change, 
plus or minus the standard deviation, that’s the infor-
mation you use to power your clinical investigation.” 
Mallinson says their focus now is on tying the 
kinds of meaningful change that clinicians and care-
givers want to see to the recovery ruler. If they can 
do that, clinicians could then have the tools to show 
families and caregivers where things are in terms of 
recovery and help families and clinicians make bet-
ter treatment decisions together.
“That’s really what drives us,” says Mallinson. “If 
we can measure things better, we can understand 
what we’re doing and how to treat patients better.” ■ 


























GW RESEARCHER ROBERT W. TURNER II,
PhD, DEVELOPS A BASELINE FOR THE
PSYCHOSOCIAL AND NEUROCOGNITIVE
FACTORS ASSOCIATED WITH
LONG-TERM EXPOSURE TO MILD
TRAUMATIC BRAIN INJURY 
BY STEVE GOLDSTEIN 
R 
obert W. Turner II has a doctorate 
in sociology from the City Uni-
versity of New York, but his most 
signifcant degree was earned 
at the School of Hard Knocks — 
more familiarly known as profes-
sional football. Turner, assistant 
professor of clinical research and 
leadership at the George Washington Univer-
sity School of Medicine and Health Sciences, 
is uniquely qualifed to explore mild Traumatic
Brain Injury (mTBI) and its relationship to cog-
nitive decline and dementia. 
“What I’m trying to do,” says Turner, who 
was an offensive lineman in the Canadian 
Football League and the NFL, “is understand 
the psychosocial and neurocognitive factors
as they are associated with accelerated cog-
nitive decline, mTBI, and potential links to 
Alzheimer’s disease and related dementia.”
The NIH-funded study will collect data using 
a mixed-method design that consists of a sur-
vey, focus groups, and in-depth interviews. 
At some point, brain imaging may also be
SCHOOL OF HARD KNOCKS
Robert Turner’s background as an
offensive lineman makes him uniquely
qualifed to explore mild Traumatic
Brain Injury and its relationship to
cognitive decline and dementia. 
employed, Turner says. His cohort will consist 
of two groups of former college and NFL play-
ers, one group with members 30–49 years old, 
and the other age 50 and above. Two similarly 
aged groups of people who have not played 
any contact sports will serve as controls. 
The three research aims will enable Turner 
to integrate and apply knowledge gained 
through the proposed training activities by 
creating a more robust portrait of psychoso-
cial protective and risk factors that may impact 
the long-term consequences of mTBI among
men than previously possible. “What we hy-
pothesize is that those who’ve had a higher 
degree of exposure to cognitive events will be 
impaired,” he says, “and we should see a cor-
relation between cognitive impairment and 
white matter degradation over time.” 
A major goal of the research is to reveal 
both the risk factors and the protective mea-
sures attending to mTBIs. “Are there things 
that these men can do that will guard against 
traumatic effects or brain injury over time?” 
Turner asks. “Do we see a link from injury to 
cognition and is that decline different from 
persons who do not sustain such an injury?” 
The study is titled “An Analysis of Psycho-
social Risk and Protective Factors: Accelerat-
ed Cognitive Aging and Mild Traumatic Brain
Injury (MTBI) Among Retired NFL & Former
NCAA Football Players.” The fve-year grant
from the National Institute of Aging concludes
in 2022.  ■ 
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GW’S SYSTEMIC APPROACH TO TREATING
CONCUSSION AND TRAUMATIC BRAIN INJURY 
BY STEVE GOLDSTEIN 
I 
n early 2018, a woman in 
her 30s, we’ll call her Sue 
although that’s not her real 
name, decided that she’d like 
to try one of those hip electric 
scooters she’d seen whizzing 
around town. Bad decision.
Unprepared for sharp turns
and close encounters with 
cars and pedestrians, Sue lost control and crashed, 
suffering a cervical vertebra injury. Rushed to the 
hospital, she was checked out by the George Wash-
ington University (GW) Hospital’s Department of 
Emergency Medicine (ED) staff and referred to the 
Department of Neurosurgery. There she had a CT 
scan to see whether there was any internal bleeding 
or a skull fracture. The scan came back negative, so 
attention shifted to the spinal injury. Ultimately, Sue 
underwent successful surgery.
Months later, still wearing a brace, Sue visited 
the Concussion and Traumatic Brain Injury (TBI) Pro-
gram Clinic at GW Hospital, complaining of head-
aches and dizziness. Marilyn F. Kraus, MD, director 
of the clinic, determined Sue had been concussed. 
“She was on pain meds, and in this case, it was hard 
for her to realize she had a concussion because of 
the lingering pain from the spinal injury, which may 
have masked the concussion effects,” says Kraus, 
who also serves as associate professor of psychiatry 
and behavioral sciences in the GW School of Medi-
cine and Health Sciences. “Almost all these c-spine 
injuries have a concussion component.” 
After Sue completed her rehabilitation from the
surgery and shed the brace, Kraus referred her to 
the GW Hospital’s spe-
cialized physical therapy A SEAMLESS APPROACH 
unit, where Senior Out- GW Hospital takes a seam-
patient Physical Therapist less, multidisciplinary
Kirsten Quinn, DPT, put approach to head injuries.
her on a therapy program Concussion and TBI are
to address the vestibular increasingly common
and GW has responded(or balance) issues. Spe-
by developing a systemiccialized physical therapy 
continuum of care for treat-for concussion and trau-
ing insults to the brain.
matic brain injury is rela-
tively recent and is a key 
component of the continuum of care at the hospital. 
Following six weeks of therapy, Sue was free of dizzi-
ness and her headaches had subsided. She decided 
to stick to Capital Bikeshare and wearing helmets 
when getting around town. 
Good decision. 
Sue’s case is illustrative of GW Hospital’s seam-
less, multidisciplinary approach to head injuries. 
Concussion and TBI are increasingly common and 
GW has responded by developing a systemic con-
tinuum of care for treating insults to the brain. Like a 
point-to-point medical map, the continuum of care 
8 NEUROTRANSMITTER FALL 2019 
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When I frst started handling care for brain 
injuries more than 20 years ago, it was like 
having a compass and a fare gun — you did the 
best you could. Now we have specialists every 
step of the way and there’s a continuity at GW. 
— Marilyn F. Kraus, MD 
    
 









































links any necessary medical services along the route 
to wellness. The map ensures each medical service 
stop along the way is close enough in proximity to 
allow immediate communication. Patients steadily
move on the road to recovery. Seems logical, right? 
Yet the idea was decades in the making, as concus-
sion and TBI swelled to become signifcant public 
health issues. 
“When I frst started handling care for brain inju-
ries more than 20 years ago, it was like having a com-
pass and a fare gun — you did the best you could,” 
says Kraus. “Now we have specialists every step of 
the way and there’s a continuity at GW.” 
The challenge is massive. According to the Cen-
ters for Disease Control and Prevention, approxi-
mately 1.5 million Americans suffer a brain injury
each year, 85,000 people suffer long-term disabili-
ties, and 50,000 people die as a result of TBI each
year. In the United States, more than 5.3 million peo-
ple live with disabilities resulting from TBI. The top
three causes of TBI are: car accidents, frearms, and
falls. Young adults and the elderly are at highest risk
for TBI, and both groups are particularly susceptible
to spinal cord injuries — another type of traumatic in-
jury that can result from those same top three causes.
DRAWING ON 20 YEARS
OF EXPERIENCE IN
TREATING BRAIN INJURIES 
Marilyn F. Kraus, MD, is the
director of the Concus-
sion and Traumatic Brain
Injury Program Clinic at
GW Hospital. She also
serves as associate
professor of psychiatry and
behavioral sciences in the
GW School of Medicine
and Health Sciences. 
PHYSICAL THERAPY
FOR BRAIN INJURIES 
Senior Outpatient Physical
Therapist Kirsten Quinn,





brain injury is relatively
recent and is a key com-
ponent of the continuum
of care at the hospital. 
The list of common symptoms of a brain injury is
long, but it includes dizziness, headache, fatigue, nau-
sea or vomiting, double or blurry vision, and diffculty
concentrating or remembering. Many people who
suffer a concussion feel better within a few days or
weeks. Others, however, may have a lengthier or more
complicated rehab, perhaps lasting months. Appro-
priate evaluation, management, and understanding
can help promote a faster, more complete recovery. 
With heightened public awareness of concussion
and TBI, the volume of cases has risen dramatically. 
According to GW’s medical records, 861 individuals
visited the concussion clinic during fscal year 2018. 
Over a period of 18 months, from the beginning of 
January 2017 through the end of June 2018, the GW 
Hospital trauma center treated 626 patients — 328 
injuries from falls, 97 from assaults, 81 from motor 
vehicle accidents, 55 pedestrian mishaps, 37 from
bicycle accidents, and eight from self-harm. There
are always outliers, of course. Kraus has treated pa-
tients who have sustained head injuries from a host 
of unique activities, including one from roller derby,
and another who had to be treated after repeatedly 
head-butting her dog. Some people will do any-
thing for fun. 
According to the Centers for Disease Control and Prevention, approximately 1.5
million Americans suffer a brain injury each year. Each year, 85,000 people suffer
long-term disabilities, and 50,000 people die as a result of a traumatic brain injury.
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Assuming those playful head butts lead to some-
thing more serious, there are a number of things pa-
tients can expect. 
When arriving in the emergency department,
the frst triage determines whether patients can be 
treated as an outpatient or if they need to be admit-
ted. One objective measure is nystagmus, some-
times known as “dancing eyes.” Out of approximate-
ly 200 patients daily, one-third have been injured (as 
opposed to a medical complaint) and, of that num-
ber, an average of two patients a day have a serious 
trauma, according to Robert Shesser, MD, MPH, pro-
fessor and chair of the Department of Emergency 
Medicine. If the concussion sustained is believed to 
be mild, the patient is given basic care guidelines 
and sent home. 
If the head injury is more severe, on the other 
hand, the patient will go to the trauma bay of the ED. 
In 2013, GW Hospital frst earned a Level 1 Trauma 
Center designation. There the self-described “mae-
stro” is Babak Sarani, MD ’97, RESD ’04, the director 
of Trauma and Acute Care Surgery at GW Hospital. 
Sarani actually functions like an orchestra conductor 
as much as a physician. 
“We start with a physical exam, including assess-
ing the patient’s level of consciousness, then we 
lean very heavily on getting a CT scan,” Sarani ex-
plains. “We look at all injuries not just brain injuries. 
Then we may initiate the consults to neurology and 
neurosurgery. We do the coordination of the care. 
Throughout the patient’s stay in the hospital, we’re 
the coordinating body. We’re the ones making sure 
the departments are talking to each other, that the 
patient is getting adequate nutrition and so on.” 
Should surgical intervention be necessary, pa-
tients are directed to GW’s Department of Neuro-
logical Surgery led by Anthony Caputy, MD, chair
of the Department of Neurological Surgery and
Hugo V. Rizzoli Professor of Neurological Surgery
SYMPTOMS OF A CONCUSSION 
A traumatic brain injury (TBI) is a type of brain injury
caused by a blow to, or penetration of, the head. A TBI
can occur during a car accident, a serious fall, an explo-
sion, or an assault, among other reasons. After a TBI,
nerve cells in the brain may be damaged. The neurons
may have trouble doing their job of carrying signals
to different parts of the brain. A concussion is a minor
form of brain injury, though some concussions can
be severe.
Typically, concussion symptoms appear soon after
an injury occurs, according to the Centers for Disease
Control and Prevention, but they can sometimes take
longer to manifest. 
> Headache 
> Dizziness or vertigo 
> Lack of awareness 
> Loss of consciousness 
> Nausea and vomiting 
> Poor attention and concentration 
> Fatigue 
> Double or blurred vision 
> Irritability and/or bothered by light or noise 
> Memory problems 
> Sleep disturbances 
A traumatic brain injury is a type of brain injury caused by a blow
to, or penetration of, the head. A TBI can occur during a car accident,
a serious fall, an explosion, or an assault among other reasons.
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their own imaging and a neurological exam, paying 
particular attention to whether there is inter-cranial 
bleeding. 
As Caputy notes: “We get more patients because 
we are a Level 1 Trauma Center. The beauty of the 
system here is that there isn’t any [discussion] of who 
takes the patient at the next stage of recovery. 
“At GW,” he adds, “the system is among the best 
in the country at ensuring patients are taken care 
of appropriately by the next expert at every level 
of care.” 
Last in the line of GW’s continuum of care is the 
Concussion/TBI Clinic, but in many ways it’s the step 
that takes patients from better to back to normal. 
Located in the neurology department, the clinic fol-
Robert Shesser, MD, MPH, 
Department of Emergency 
patients a day, on average, 



















at SMHS. The department is staffed by a team of
experts trained in all aspects of the treatment and
management of neurological disorders. As a disci-
pline, neurosurgery covers a large number of pro-
cedures from minimally invasive techniques for the
brain and spine — deep brain stimulation to treat
movement and mood disorders, craniotomy tech-
niques for mapping brain function, radiosurgery,
carotid artery stenting, and minimally invasive
treatment of brain aneurysm (coiling) — to more tra-
ditional open surgeries to relieve cranial pressure,
treat traumatic brain injury, or correct malforma-
tions of blood vessels. 
“Neurosurgery is the acute part of the continuum 
of care, and, along with the trauma team, we are the 
initial evaluators,” says Michael Rosner, MD, profes-
sor of neurological surgery, and a key member of 
Caputy’s surgical team. Rosner brings vast experi-
ence with TBI cases. Before coming to GW, Rosner 
was a staff neurosurgeon at Walter Reed, and he 
also served with the 86th Combat Support Hospital 
in Baghdad, Iraq, in support of Operation Iraqi Free-
dom. As soon as the trauma team identifes any kind 
of neurological concern, “we are there within sec-
onds,” Rosner says, adding the neurosurgeons do 
TREATING TRAUMA 
professor and chair of the
Medicine, (left), said two
have a serious trauma. In
those cases, the patient
goes to the trauma bay
of the ED, where Babak
Sarani, MD ’97, RESD ’04,
is the director of Trauma
and Acute Care Surgery. 
lows patients and organizes care soon after injury. 
Patients receive treatment across the full range of 
their recovery, from post-operative to the weeks, 
months, or even years after the precipitating event. 
Treatment can range from the subacute phase, when 
the injury is just starting to heal, into the chronic 
phase, typically six months after an injury and con-
tinuing throughout the patient’s life, as needed. 
“We see athletes, as well as any other types of 
head injury, including motor vehicle and work-
... [N]eurosurgery covers a large number of procedures from
minimally invasive techniques for the brain and spine … to more
traditional open surgeries … . 
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related incidents,” says Kraus, adding that each case 
requires a complete evaluation in order to develop a 
comprehensive treatment plan. No two brain injuries 
are alike and the consequence of two similar injuries 
may be very different. 
“We address all the potential abnormal conditions 
relating to TBI/concussion, including headache, neck
pain, vestibular disorders, oculomotor disorders,
sleep disorders, cognitive and mood changes,” she 
adds. “Symptoms may appear right away or may not 
be present for days or weeks after the injury. One of 
the consequences of brain injury is that the person of-
ten does not realize that a brain injury has occurred.” 
When Kraus evaluates a patient who is complain-
ing of cognitive diffculty that is interfering with daily 
life, she frequently refers them to neuropsychiatrist
Antonio Puente, PhD, who performs a detailed neu-
ropsychological exam designed to produce cogni-
tive measures through memory, problem solving,
and attention exercises. “This will provide cognitive 
measures but also tells us how the patient is doing 
emotionally and helps inform treatment,” Puente ex-
plains. “More often than not, our fndings are used to 
change their physical routine.” 
Ultimately, patients are referred for physical
therapy (PT). Senior Outpatient Physical Therapist
Kirsten Quinn is a trained therapist specializing in
concussion and TBI. Her department receives be-
tween 10 and 20 new patients each week suffer-
ing from TBI/concussion. They are scheduled for
all three therapy disciplines: speech, physical, and
occupational “to make sure we’re not missing any-
thing,” Quinn explains. Sessions are scheduled in
the hospital but the patient is also expected to do
his/her exercises at home. Vestibular, or balance,
dysfunction is a common reason patients are re-
ferred for PT. “It’s in the patients’ best interest to
have this close-knit relationship among all our
[medical] teams,” she adds, “because we can bet-
ter manage the patient and ensure all their needs
are handled.” 
For patients such as Sue, GW offers an impor-
tant blend of both the immediacy of treatment 
and the availability of follow-up care. “The system 
in place is designed to handle all comers, at all 
stages, no matter the cause of the head injury,” 
says Kraus. Even someone concussed by bang-
ing heads with the family pet. “I never did get a 
clear answer why she was playing chicken with 
her dog.”  ■ 
FIELD EXPERIENCE 
Michael Rosner, MD, profes-
sor of neurological surgery,
is a key member of GW’s
neurosurgery team. Before
coming to GW, Rosner
was a staff neurosurgeon
at Walter Reed, and he
also served with the 86th
Combat Support Hospital in
Baghdad, Iraq, in support




tion be necessary as a
result of a traumatic
brain injury, patients are
directed to GW’s Depart-
ment of Neurological
Surgery led by Anthony
Caputy, MD, chair of the
Department of Neurologi-
cal Surgery and Hugo V.
Rizzoli Professor of Neuro-
logical Surgery at SMHS.
GW offers an important blend of both the immediacy of treatment and
the availability of follow-up care. The system is designed to handle
all comers, at all stages, no matter the cause of the head injury.
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Turning to Biomarker to Put TBI Symptoms in the Past 
C ould the brain provide biologicalclues following a traumatic injurythat would improve the outcome forthe patient? The George WashingtonUniversity (GW) Hospital is part-nering in a new study to determine
whether biomarkers in a patient who
has suffered a traumatic brain injury
(TBI) can help reduce the risk of post-TBI symptoms
such as post-traumatic stress disorder. TBIs account
for the onset of PTSD
in approximately
REDUCING THE RISK OF PTSD 700,000 Americans
GW University Hospital is partner-
each year. Depressioning in a new study to determine
and post-concus-whether biomarkers in a patient
sive syndrome (PCS)who has suffered a traumatic
brain injury can help reduce are also common in
the risk of post-TBI symptoms. patients who develop
Researchers Look to Prevent
Post-Traumatic Stress Disorder
Among Patients Suffering Brain Injuries 
BY STEVE GOLDSTEIN 
PTSD. Research suggests, however, that if the deter-
minants of risk are better analyzed and understood
there is a better chance of successful preventive
interventions. 
Along with Walter Reed National Military Medical
Center (Walter Reed) and the National Institutes
of Health, GW’s School of Medicine and Health
Sciences (SMHS) Department of Neurological
Surgery is collaborating in a study funded by the
Henry M. Jackson Foundation for the Advancement
of Military Medicine. Jessica Gill, PhD, of the
National Institute of Nursing Research, is serving
as principal investigator. Gill has been exploring
the mechanisms underlying neurological symp-
toms and defcits in military personnel with TBIs,
as well as athletes with concussions. This line of
inquiry employs a cutting-edge type of biomarker
harvesting technology using a nanoparticle cap-
ture platform in a prospective sample of patients
immediately following a trauma. Findings from her
research will identify the clinical and biological risks
Traumatic brain injuries account for the onset of PTSD 
in approximately 700,000 Americans each year.
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Depression and post-concussive syndrome are common in patients who 
develop PTSD. Research suggests that if the determinants of risk are better 
understood there is a better chance of successful preventive interventions. 
that predict PTSD onset and neurological compro-
mise following a traumatic injury. 
SMHS serves as a site for sample collec-
tion from civilian patients. Gill is joined on the
Jackson grant by Anthony Caputy, MD, chair of
the Department of Neurological Surgery and
Hugo V. Rizzoli Professor of Neurological Surgery
at SMHS, and Babak Sarani, MD ’97, RESD ’04,
director of the Center for Trauma and Critical
Care at GW Hospital and associate professor of
PTSD SIGNS AND SYMPTOMS 
For some people, frightening memories of a terrible
event can come back months or even years after the
event, making daily life diffcult to handle. Mental health
experts call this post-traumatic stress disorder (PTSD).
One myth about PTSD is that it most often affects 
war veterans or survivors of violent assaults, but those 
who have experienced bad accidents, fres, or natural 
disasters, and emergency response workers, such as 
police, frefghters, and medical providers, can also ex-
perience the disorder. 
People with PTSD may feel anxious or hyper-alert. 
Other signs of PTSD include: 
> Having frequent nightmares, fashbacks,  
or other vivid memories of the event 
> Being unable to recall parts of the event 
> Staying away from any reminders of the event,  
including people, places, thoughts, or activities 
> Feeling always on guard or on edge 
> Having trouble sleeping 
surgery and of emergency medicine at SMHS. The
subjects are individuals who have had a severe
closed (non-penetrating) head injury resulting from
a fall, a car accident, or an assault, to name some
examples. Researchers are collecting specimens
from these patients,  specifcally blood and cerebro-
spinal fuid, in order to search for these biomarkers
that could predict an outcome. By examining the
proteins and lipids in the serum of the cerebrospinal
fuid they hope to determine if the level of con-
sciousness changed.
Current scanning technologies — CT, MRI, and
other techniques — do not necessarily reveal what’s
happening at the molecular level in the brain.
According to the researchers, some small evidence
of head injury can be observed in these scans, but it’s
not that good and not very predictive of the patient’s
long-term outcome. The goal of the project is to
identify a molecular marker to correlate with clinical
examinations and imaging fndings to better predict
patient outcomes and improve their care.
Gill’s research suggests that DNA methylation
may be a putative biomarker of psychiatric risk,
as it refects long-term changes in the function
of the gene and may shape the recovery ability of
the TBI patient through changes in cell function.
Moreover, the neuroendocrine system appears to
have a determine role. Prior research has shown
that both PTSD and depression are associated with
endocrine alterations, “leading us to question if this
biological change may underlie vulnerability for
the onset of PTSD as well as depression and post-
concussive syndrome following a TBI,” according to
Gill’s hypothesis. “In support of the idea of shared
vulnerability, patients with a TBI also often display
endocrine function alterations.” 
Samples are still being collected at GW, from
approximately 50 individuals, ages 18 to 65, and data
continues to be tabulated and analyzed at the NIH.  ■ 
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GW Researchers Receive 
$7.8 Million to Establish 
Rare Disease Network for 
Myasthenia Gravis 
A
George Washington University (GW) research
team led by Henry Kaminski, MD, chair of the
Department of Neurology and Meta Amalia Neu-
mann Professor of Neurology at the GW School
of Medicine and Health Sciences (SMHS), recently
received a $7.8 million award from the National In-
stitutes of Health (NIH) to establish a rare disease
network for myasthenia gravis. The network, which
will join 24 existing NIH Rare Diseases Clinical Re-
search Networks, will include basic and clinical in-
vestigators, patient advocacy groups, and biotech-
nology and pharmaceutical companies working
together to enhance therapeutic development for
this rare disease. 
A $7.8 million grant from the National Institutes
of Health will fund research into the underlying
pathophysiology of myasthenia gravis. The different
subtypes of myasthenia gravis are not well understood,
and few research labs are studying the disease.
Kaminski, a renowned expert in myasthenia gra-
vis who has devoted decades of study to the dis-
ease, is joined on the team by fellow investigators
Linda Kusner, PhD, associate research professor of
pharmacology and physiology at SMHS, and Alison
Hall, PhD, associate dean for research workforce
development at SMHS.
“Myasthenia gravis is a chronic autoimmune dis-
ease that affects how well the nerves and muscles
communicate with each other. Often patients ex-
perience extreme weakness, struggle with their
vision, and are even hospitalized because of diff-
culty breathing,” says Kaminski. “This grant will give
the researcher community the needed infrastruc-
ture to study this rare disease in order to develop
new therapies.” 
The grant will fund research into the underly-
ing pathophysiology of the disease. The different
subtypes of myasthenia gravis are not well under-
stood, there are no known biomarkers, and few
research labs are studying the disease. Upward
of 30% of patients are treatment resistant, and
all suffer from undesirable or dangerous adverse
treatment side effects. The research team will fo-
cus on the differences between ocular myasthenia
and general myasthenia — subtypes that produce
different antibodies that begin attacking nerve
and muscle communication — and individualized
treatments for the 10% of myasthenia gravis pa-
tients who develop tumors triggered by the dis-
ease. Additionally, the researchers will identify
and collect biospecimens for future study and fol-
low myasthenia gravis patients in order to identify
biomarkers.
To increase the research into myasthenia gravis,
the grant also will support a career enhancement
component featuring training and education op-
portunities for scientists, physicians, and the lay
public. These opportunities will not only increase
the pool of young investigators focusing their ca-
reers on rare diseases, specifcally myasthenia gra-
vis, but improve awareness of the unique needs of
myasthenia gravis patients.
“The grant is not just a single project, but the
establishment of a resource that will drive research
for many years,” says Kaminski. “Other rare disease
networks funded in the last 10 years have advanced
treatments for these disorders that otherwise
would have been impossible.”  ■
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